litlas
Log inCreate account

Lesley Fallowfield

Active 1986–2025

149
Papers
42,048
Citations
101
h-index
146
i10-index

Citations

Citations per year for Lesley Fallowfield1971: 1 citations1974: 2 citations1981: 1 citations1988: 3 citations1989: 7 citations1990: 8 citations1991: 10 citations1992: 13 citations1993: 14 citations1994: 18 citations1995: 35 citations1996: 27 citations1997: 44 citations1998: 52 citations1999: 123 citations2000: 119 citations2001: 123 citations2002: 135 citations2003: 165 citations2004: 177 citations2005: 284 citations2006: 250 citations2007: 314 citations2008: 358 citations2009: 292 citations2010: 280 citations2011: 262 citations2012: 259 citations2013: 243 citations2014: 244 citations2015: 244 citations2016: 258 citations2017: 276 citations2018: 229 citations2019: 1,032 citations2020: 1,189 citations2021: 1,152 citations2022: 826 citations2023: 617 citations2024: 1,037 citations2025: 346 citations2026: 10 citations1972–1973: no citations, so these years are not shown1975–1980: no citations, so these years are not shown1982–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,039 citing papers, 21.8% of this breakdownUnited Kingdom: 1,547 citing papers, 11.1% of this breakdownChina: 798 citing papers, 5.7% of this breakdownItaly: 749 citing papers, 5.4% of this breakdownGermany: 666 citing papers, 4.8% of this breakdownCanada: 654 citing papers, 4.7% of this breakdownAustralia: 620 citing papers, 4.5% of this breakdownNetherlands: 512 citing papers, 3.7% of this breakdownFrance: 474 citing papers, 3.4% of this breakdownSpain: 406 citing papers, 2.9% of this breakdownSwitzerland: 397 citing papers, 2.9% of this breakdownBelgium: 359 citing papers, 2.6% of this breakdown
0%21.8%Other 26.5%

Institutions

Fields

  • Medicine61.1%
  • Biochemistry, Genetics and Molecular Biology21.3%
  • Health Professions9.9%
  • Psychology1.3%
  • Social Sciences1%
  • Computer Science1%
  • Other4.4%

Topics

  • Cancer survivorship and care6.3%
  • Breast Cancer Treatment Studies5.9%
  • Patient-Provider Communication in Healthcare3.8%
  • Advanced Breast Cancer Therapies3.5%
  • Ovarian cancer diagnosis and treatment2.7%
  • HER2/EGFR in Cancer Research2.5%
  • Other75.3%

Coauthors

All papers

Open in search
  1. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    Authors: Fátima Cardoso, Shani Paluch–Shimon, Elżbieta Senkus, Giuseppe Curigliano, Matti Aapro, Fabrice André, C.H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Frances Boyle, Maria João Cardoso, L.A. Carey, Javier Cortés, Nagi S. El Saghir, Mona Elzayat, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Karen A. Gelmon, Joseph Gligorov, Renate Haidinger, Nadia Harbeck, Xin Hu, Bella Kaufman, Rajneesh Kaur, Belinda E. Kiely, S.-B. Kim, NU Lin, Shirley Mertz, Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer - Annals of Oncology 2020 cited by 1,356

  2. Ovarian Cancer Population Screening and Mortality After Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial

    Authors: Usha Menon, Aleksandra Gentry‐Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan Massingham, Maria Raikou, Jatinderpal Kalsi, Robert Woolas, Ranjit Manchanda, Rupali Arora, Laura Casey, Anne Dawnay, Stephen Dobbs, Simon Leeson, Tim Mould, Mourad W. Seif, Aarti Sharma, Karin Williamson, Yiling Liu, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Steven J. Skates, Ian Jacobs, Mahesh Parmar - Obstetrical & Gynecological Survey 2021 cited by 700

  3. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    Authors: Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 cited by 2,062

  4. Ovarian cancer

    Authors: Ursula A. Matulonis, Anil K. Sood, Lesley Fallowfield, Brooke E. Howitt, Jalid Sehouli, Beth Y. Karlan - Nature Reviews Disease Primers 2016 cited by 1,291

  5. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

    Authors: Massimo Di Maïo, Ethan Basch, Fabrice Denis, Lesley Fallowfield, Patricia A. Ganz, Doris Howell, Christoph Kowalski, Francesco Perrone, Angela M. Stover, Puma Sundaresan, Lorraine Warrington, L. Zhang, Kathi Apostolidis, J. Freeman-Daily, Carla Ripamonti, Daniele Santini - Annals of Oncology 2022 cited by 480

  6. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

    Authors: Ian Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry‐Maharaj, Matthew Burnell, Jatinderpal Kalsi, Nazar N. Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank, Danielle N Crump, Susan K Davies, Anne Dawnay, Stephen Dobbs, G. Fletcher, Jeremy Ford, Keith Godfrey, Richard Gunu, Mariam Habib, Rachel Hallett, Jonathan Herod, Howard J. Jenkins, Chloe Karpinskyj, Simon Leeson, Sara Lewis, William R Liston, Alberto Lopes, Tim Mould, John Murdoch, David Oram, Dustin J. Rabideau, Karina Reynolds, Ian Scott, Mourad W. Seif, Aarti Sharma, Naveena Singh, Julie Taylor, Fiona Warburton, Martin Widschwendter, Karin Williamson, Robert Woolas, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Steven J. Skates - The Lancet 2015 cited by 1,102

  7. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

    Authors: Fátima Cardoso, Elżbieta Senkus, A. Costa, Efthymios Papadopoulos, Matti Aapro, Fabrice André, Nadia Harbeck, B. Aguilar Lopez, C.H. Barrios, Jonas Bergh, Laura Biganzoli, C.B. Boers-Doets, Maria João Cardoso, L.A. Carey, Javier Cortés, Giuseppe Curigliano, Véronique Dièras, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, P.A. Francis, Karen A. Gelmon, S. Johnston, Bella Kaufman, Smruti Koppikar, I.E. Krop, Musa Mayer, Gertrude Nakigudde, B.V. Offersen, Shinji Ohno, Olivia Pagani, Shani Paluch–Shimon, Frédérique Penault‐Llorca, Aleix Prat, H.S. Rugo, G. W. Sledge, Danielle Spence, Christoph Thomssen, D.A. Vorobiof, B. Xu, Larry Norton, E.P. Winer - Annals of Oncology 2018 cited by 1,190

  8. Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

    Authors: Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jahanzeb, Stephen Johnston, Larissa A. Korde, James Khatcheressian, Rita S. Mehta, Hyman B. Muss, Harold J. Burstein - Journal of Clinical Oncology 2016 cited by 645

  9. Digital Health for Optimal Supportive Care in Oncology: Benefits, Limits, and Future Perspectives

    Authors: Matti Aapro, Paolo Bossi, Arvind Dasari, Lesley Fallowfield, Pau Gascon, Melissa A. Geller, Katja-Daniela Jordan, Jin‐Hwan Kim, K. Martin, S. Porzig - Kompass Nutrition & Dietetics 2020 cited by 326

  10. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

    Authors: Fátima Cardoso, Shani Paluch–Shimon, Eva Schumacher-Wulf, Leonor Vasconcelos de Matos, Karen A. Gelmon, Matti Aapro, Jyoti Bajpai, Carlos H. Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A. Carey, Mariana Chávez‐MacGregor, Runcie C.W. Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca Dent, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Sandra X. Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J. Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda E. Kiely, Sungbae Kim, Smruti Koppikar, Marion Kuper‐Hommel, Frédéric Lecouvet, Ginny Mason, Shirley Mertz, Volkmar Müller, Claire Myerson, Silvia P. Neciosup, Birgitte Vrou Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault‐Llorca, Aleix Prat, Hope S. Rugo, Elżbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer - The Breast 2024 cited by 197

  11. Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

    Authors: Robert E. Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G. Newcombe, J. Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny, David England, Mark Sibbering, Tholkifl I. Abdullah, Lester Barr, U Chetty, Dudley H. Sinnett, Anne Fleissig, Dayalan Clarke, Peter J. Ell - JNCI Journal of the National Cancer Institute 2006 cited by 1,675

  12. Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review

    Authors: Kelly L. Stoner, Helena Harder, Lesley Fallowfield, Valerie Jenkins - Patient 2014 cited by 160

  13. Addressing overtreatment of screen detected DCIS; the LORIS trial

    Authors: Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M.S. Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young, Lucinda Billingham, David Dodwell, Andrew M. Hanby, Sarah E. Pinder, Andrew Evans, Malcolm Reed, Valerie Jenkins, Lucy Matthews, Maggie Wilcox, Patricia Fairbrother, S. Bowden, Daniel Rea - European Journal of Cancer 2015 cited by 375

  14. Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

    Authors: Harold J. Burstein, Angela DeMichele, Lesley Fallowfield, Mark R. Somerfield, N. Lynn Henry, for the Biomarker Testing and Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panels, N. Lynn Henry, Zoneddy Dayao, Anthony Elias, Kevin Kalinsky, Lisa M. McShane, Beverly Moy, Ben Ho Park, Kelly M. Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica Stringer-Reasor, Melinda L. Telli, Nicholas C. Turner, Angela DeMichele, Harold J. Burstein, Debra L. Barton, Ali Dorris, Lesley Fallowfield, Dharamvir Jain, Stephen Johnston, Larissa A. Korde, Jennifer K. Litton, Erin Macrae, Lindsay L. Peterson, Praveen Vikas, Rachel L. Yung, Hope S. Rugo - Journal of Clinical Oncology 2024 cited by 48

  15. Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

    Authors: Xavier Pivot, Joseph Gligorov, Volkmar Müller, Peter Barrett‐Lee, Sunil Verma, Ann Knoop, Giuseppe Curigliano, Semiglazov Vf, Guillermo López-Vivanco, Valerie Jenkins, Nana Scotto, Stuart Osborne, Lesley Fallowfield - The Lancet Oncology 2013 cited by 226

  16. Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

    Authors: Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz, Lesley Fallowfield, Päivi Auvinen, Catarina Pulido, Ana Cvetanović, Sharon Wilks, Leonor Ribeiro, Mauricio Burotto, Dirk Klingbiel, Dimitri Messeri, Ari Alexandrou, Peter C. Trask, J. Fredriksson, Z. Machackova, Ljiljana Stamatović, Ernesto Korbenfeld, Jorge Nadal, Hélio Pinczowski, Felipe José Silva Melo Cruz, Gustavo Mota de Sousa, Aline Coelho Gonçalves, Gisah Guilgen, Mauricio Burotto, Antti Jekunen, Päivi Auvinen, Winne Yeo, Eric C. K. Cheng, Hikmat A. Razeq, Fadi Rafic El Karak, Fadi Farhat, Servando C. Huerta, Brizio M. Jaime, Juan P. Feregrino, O. Castillo, Juan Carlos Alcedo, Leonor Ribeiro, Maria Rita Dionísio, Susana Sousa, Catarina Pulido, Salha Bujassoum, Hatoon Bakhraibah, Ana Cvetanović, Ljiljana Stamatović, Álvaro Rodríguez Lescure, Josefina Cruz, Camilla Wendt, Sara Margolin, Helena Granstam Björneklett, Michelina Cairo, Shaker R. Dakhil, Nguyet Le‐Lindqwister, Ling Ma, Kristi McIntyre, Joyce O’Shaughnessy, Svetislava J. Vukelja, Donald Richards, Sharon Wilks, John M. Wallmark - European Journal of Cancer 2021 cited by 74

  17. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction

    Authors: S. K. Al-Ghazal, Lesley Fallowfield, R.W. Blamey - European Journal of Cancer 2000 cited by 653

  18. Multidisciplinary teams in cancer care: are they effective in the UK?

    Authors: Anne Fleissig, Valerie Jenkins, Susan Catt, Lesley Fallowfield - The Lancet Oncology 2006 cited by 617

  19. Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial

    Authors: Usha Menon, Aleksandra Gentry‐Maharaj, Matthew Burnell, Andy Ryan, Naveena Singh, Ranjit Manchanda, Jatinderpal Kalsi, Robert Woolas, Rupali Arora, Laura Casey, Anne Dawnay, Aarti Sharma, Karin Williamson, Sophia Apostolidou, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Steven J. Skates, Ian Jacobs, Mahesh Parmar - The Lancet Oncology 2023 cited by 57

  20. A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot

    Authors: Bethany Torr, Christopher I. Jones, Subin Choi, Sophie Allen, Grace Kavanaugh, Monica Hamill, Alice Garrett, Suzanne MacMahon, Lucy Loong, Alistair Reay, Lina Yuan, Mikel Valganon Petrizan, Kathryn Monson, Nicky Perry, Lesley Fallowfield, Valerie Jenkins, Rochelle Gold, Amy Taylor, Rhian Gabe, Jennifer Wiggins, Anneke Lucassen, Ranjit Manchanda, Ashu Gandhi, Angela George, Michael Hubank, Zoe Kemp, D. Gareth Evans, Stephen Bremner, Clare Turnbull - Journal of Medical Genetics 2022 cited by 30

  21. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    Authors: Usha Menon, Aleksandra Gentry‐Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, S. J. Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W. Seif, Ian Scott, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Nazar N. Amso, Simon Leeson, Derek Cruickshank, Alistair McGuire, Stuart Campbell, Lesley Fallowfield, Naveena Singh, Anne Dawnay, Steven J. Skates, Mahesh Parmar, Ian Jacobs - The Lancet Oncology 2009 cited by 834

  22. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

    Authors: Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry‐Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell, S. J. Davies, Aarti Sharma, Richard Gunu, Keith Godfrey, Alberto Lopes, David Oram, Jonathan Herod, Karin Williamson, Mourad W. Seif, Howard J. Jenkins, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Nazar N. Amso, Simon Leeson, Derek Cruickshank, Ian Scott, Lesley Fallowfield, Martin Widschwendter, Karina Reynolds, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Steven J. Skates, Ian Jacobs - Journal of Clinical Oncology 2015 cited by 198

  23. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial

    Authors: PulMiCC Trial Group, Tom Treasure, Vernon T. Farewell, Fergus Macbeth, Kathryn Monson, Norman Williams, Chris Brew‐Graves, Belinda Lees, Olivia Grigg, Lesley Fallowfield - Trials 2019 cited by 216

  24. Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    Authors: James Dilley, Matthew Burnell, Aleksandra Gentry‐Maharaj, Andy Ryan, Christina Neophytou, Sophia Apostolidou, Chloe Karpinskyj, Jatinderpal Kalsi, Tim Mould, Robert Woolas, Naveena Singh, Martin Widschwendter, Lesley Fallowfield, S. Campbell, Steven J. Skates, Alistair McGuire, Mahesh Parmar, Ian Jacobs, Usha Menon - Gynecologic Oncology 2020 cited by 76